Picosulfate dosage form
AssigneeThe Procter & Gamble Company
InventorsKenneth G. Mandel, Paula D. Davis
Life of this patent
Estimating the term…
Abstract
A pharmaceutical laxative composition in unit dosage form, for peroral administration of picosulphate to a human or other animal subject, comprising a safe and effective amount of picosulphate in a rapidly dissolving matrix; and a proximal colonic delivery carrier which effects release of said picosulphate substantially near the junction between the small intestine and the colon or within the colon of said subject. This invention also involves methods for providing laxation for humans and other animals in need thereof by peroral administration of such compositions.
Claims13
A pharmaceutical laxative composition in unit dosage form, for peroral administration of picosulphate to a human or other animal subject, comprising:
- (a) from about 0.1 mg to about 10 mg of picosulphate in a rapidly dissolving matrix;
- and
- (b) a proximal colonic delivery carrier which effects release of said picosulphate substantially near the junction between the small intestine and the colon or within the colon of said subject:
- wherein the picosulphate dissolves substantially completely within about 1 minute to about 20 minutes from the matrix once dissolution commences.
Dependencies are inferred from the claim text.